1 completed, 1 terminated. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Terminated 1 |
Follow AlloCure Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Safety and Efficacy of AC607 for the Treatment of Kidney Injury in Cardiac Surgery Subjects AC607, Vehicle Only - Acute Kidney Injury | Phase 2 | Terminated | AlloCure Inc. | 156 | 2012-06-01 | 2014-08-06 |
| Allogeneic Multipotent Stromal Cell Treatment for Acute Kidney Injury Following Cardiac Surgery Multipotent Stromal Cells, Administration of MSC - Kidney Tubular Necrosis, Acute | Phase 1 | Completed | AlloCure Inc. | 15 | 2008-08-01 | 2014-08-06 |
Acute Kidney Injury (1) · Kidney Tubular Necrosis, Acute (1)
United States (2) · Canada (1)
Christof Westenfelder, MD (1) · Viken Paragamian (1)